Array Imaging digital PCR Platform
Array Imaging digital PCR Platform
批准号:
9768589
负责人:
Paul Ju-Sung Hung
金额:
$60.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-06-15 至 2021-07-31
关键词:
AdoptionAirAttentionAutomationBiological AssayBiological MarkersCapitalChemistryClinical ResearchCollaborationsColorComb animal structureCommunitiesComplementComputer softwareConsultationsCost efficiencyDataDevelopmentDevicesDiagnosisDyesEmulsionsEnzyme ActivationEventGeneticGenetic MarkersGenomicsGoalsImageImage AnalysisIndustrializationInjectionsInterferometryLasersLegal patentLettersLiquid substanceMalignant NeoplasmsMarket ResearchMeasuresMicrofluidicsMoldsMonitorMutationMutation DetectionNucleic AcidsOilsOpticsPerformancePhaseProcessProductionReagentRecipeResearchRunningSamplingSan FranciscoSlideSmall Business Innovation Research GrantSpecificityStatistical Data InterpretationStatistical ModelsSystemTechnologyTemperatureTestingTimeTreatment EfficacyViral Load resultcell free DNAcommercializationcostdesigndigitaldigital imagingdisorder preventionexperimental studyfluorescence imaginggraphical user interfaceimage processingimaging Segmentationimaging capabilitiesimaging platformimprovedinnovationinstrumentlight intensityoff-patentoperationoutcome forecastpressureproduct developmentprototyperare cancerreal-time imagessensorstatistics
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
Combinati is looking to bring an integrated Array Imaging digital PCR platform with injection molded
microfluidic consumables from lab to marketplace to accelerate the adoption of dPCR technology. Digital
PCR has drawn attentions in both genomic research and clinical research communities for its ability to
detect rare events (high sensitivity), less prone to inhibition (high specificity), no need for an internal
standard (high precision), and access to well-developed PCR reagents. However, current dPCR instruments
are capital intensive, cost per sample is high, and the workflow is complicated. With successful completion
of our Phase 1 aims, we will continue the following product development effort to bring our platform to
market with the following differentiated features
• Smooth transition from qPCR:
o Equivalent workflow: The user will add the reagent mix to the consumable, reagent
digitization, thermal cycling, and real-time imaging is vertically integrated into one
instrument.
o Cost efficiency:
▪ Instrument: The advance in imaging, thermal control and pneumatic control
technologies allow us to sell the instrument at ~$30k, similar to qPCR instruments.
▪ Consumable: The scalable injection molding technology enables low cost per data
point (<$1).
o Open assay chemistry: The reagents will be partitioned in plastic microchambers instead
of proprietary emulsion oil. The user’s qPCR recipe can be directed transitioned to our
dPCR platform.
o Automation compatible: The standard plate frame allows the user to automate the dPCR
process with liquid handlers.
• More robust and consistent data:
o Real-time imaging during thermal cycling: By subtracting from background pre-thermal
cycling image from the post-thermal cycling image, as well as recording amplification
dynamics of each partition, the user is able to count only partitions showing PCR to
minimize false positive calls.
o Fixed number of partitions for every data point: Poisson statistics is dependent on the
total number of partitions. Our consumable will guarantee 20k partitions for each data
point, unlike ddPCR, which varies between 11k to 19k.
o Known volume: Quantification is done by dividing the number of molecules to the total
volume. The volume of our array will be measured with confocal laser interferometry to
give the user precise volume for quantification.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Digital Melt Curve Analysis Platform for Longitudinal Cancer Patient Monitoring
-
批准号:10256226
-
项目类别:
-
资助金额:$77.27万
-
财政年份:2021
-
负责人:Paul Ju-Sung Hung
-
依托单位:
Micromolded Digital Nucleic Acid Test Consumable
-
批准号:9347291
-
项目类别:
-
资助金额:$21.5万
-
财政年份:2017
-
负责人:Paul Ju-Sung Hung
-
依托单位:
Microfluidic Liver Array for Drug Metabolite Profiling
-
批准号:8036092
-
项目类别:
-
资助金额:$44.48万
-
财政年份:2010
-
负责人:Paul Ju-Sung Hung
-
依托单位:
Microfluidic Liver Array for Drug Metabolite Profiling
-
批准号:7804425
-
项目类别:
-
资助金额:$45.18万
-
财政年份:2010
-
负责人:Paul Ju-Sung Hung
-
依托单位:
Microfluidic Bioreactor for High Throughput Hepatotoxicity Screening
-
批准号:7595066
-
项目类别:
-
资助金额:$34.05万
-
财政年份:2006
-
负责人:Paul Ju-Sung Hung
-
依托单位:
Microfluidic Bioreactor for High Throughput Hepatotoxicity Screening
-
批准号:7926454
-
项目类别:
-
资助金额:$8.23万
-
财政年份:2006
-
负责人:Paul Ju-Sung Hung
-
依托单位:
Microfluidic Bioreactor for High Throughput Hepatotoxicity Screening
-
批准号:7482512
-
项目类别:
-
资助金额:$34.38万
-
财政年份:2006
-
负责人:Paul Ju-Sung Hung
-
依托单位:
国内基金
海外基金
湍流和化学交互作用对H2-Air-H2O微混燃烧中NO生成的影响研究
-
批准号:51976048
-
项目类别:面上项目
-
资助金额:61.0万元
-
批准年份:2019
-
负责人:邱朋华
-
依托单位: